Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,681   12.00  Index Moved Up 0.72%
FNMFO FNMFO 096770 KDDIF Large Blend Conglomerates Index Choice Action Alerts 
United States GSPC USD ...  |  Create Portfolios


Processing
Collecting data for MRX

Medicis quote and profile

 
 Companies |  Insiders  | Dashboard  
     
43.98
  
STOCK
0.00  No Change   0.00%  
Year To Date
0.043.98
May 22 2013 

Diversification Suggestion

Use Medicis to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
Check current 30 days Medicis correlation with market (S&P 500)
1 Month Beta 0.0  
Unless we do not have data at the moment the returns on S&P 500 and Medicis are completely uncorrelated
Medicis Pharmaceutical Corp not significant BetaMedicis Pharmaceutical Beta Legend
MRX United States AMEX
Medicis Pharmaceutical Corp
Benchmark S&P 500
http://www.medicis.com
Contact Number: 602. 808. 8800
Traded on American Stock Exchange
    
Current Valuation2.32 B
Shares Outstanding56.42 M
Number of Shares Shorted5.09 M
Revenue759.21 M
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States Russel   0.75 % Macroaxis: 0.75 Moved Up  
 
 United States SP 500   0.67 % Macroaxis: 0.67 Moved Up  
 
 United States NYSE   0.58 % Macroaxis: 0.58 Moved Up  
 
 thisGreen MRX MRX agains markets  0.00 % No Change  
Compare to Competition Get Alpha   Get Advice

Medicis Leadership

Jonah Shacknai Founder, Chairman, CEO and Member of Executive Committee
Vincent Ippolito Executive Vice President - Sales and Marketing
Seth Rodner Executive Vice President Secretary
Mark Prygocki President

Medicis Summary

Medicis Pharmaceutical Corp [MRX] is traded on American Stock Exchange in USA. It is located in Scottsdale, AZ and employs 646 people. The company currently falls under 'Mid-Cap' category with total capitalization of 2.48 B. Medicis Pharmaceutical Corp has 56.42 M outstanding shares of which 5.09 M shares are now shorted by investors with about 2.9 days to cover shorted positions.
Medicis Pharmaceutical Corporationration, a specialty pharmaceutical company, engages in the development and marketing of various solutions for the treatment of dermatological and aesthetic conditions in the United States and Canada. more
Follow Medicis with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Medicis to your reader
 

Medicis Research Report

Medicis vs. Federal

Correlation analysis and fundamentals comparison between Medicis Pharmaceutical and Federal National Mor

Medicis Executives

Richard Peterson CFO, Chief Accounting Officer, Executive VP and Treasurer
Jason Hanson COO and Executive VP

Medicis Directors

Spencer Davidson Independent Director, CFA
Peter Knight Independent Director
Giuseppe Ariti Executive Director, MBA
Philip Schein Independent Director
Stuart Diamond Independent Director

Medicis Management

Mark Sr President
Claire Tolcon Company Secretary

Medicis Fundamentals

Price to Earning vs Z Score
EBITDA vs Retained Earnings
Price to Earning vs Cash Flow from Operations
Shares Owned by Insiders vs Retained Earnings

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium